Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00108589 · ClinicalTrials.gov registry record · Phase 3
S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis
A Phase 3 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00108589 is a Phase 3 study that has completed, run by US Department of Veterans Affairs.
The verdict
NCT00108589, a Phase 3 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
The purpose of this study is to examine the effect of S-adenosylmethionine therapy in those patients with non-alcoholic liver disease in the form of steatohepatitis (NASH). This will be accomplished by development of a database of these patients, all of whom will have biopsy documented NASH. A placebo controlled trial will then examine the effect of S-adenosylmethionine over time on clinical outcome in these patients. It is expected that this agent will slow or halt the progression of this disease.
Interventions
- DRUG S-adenosylmethionine
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-01 |
| Est. Completion | 2006-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00108589
The ClinicalTrials.gov registry entry for NCT00108589 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which S-adenosylmethionine is the first listed.
NCT00108589 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00108589 about?
NCT00108589 is a clinical study titled "S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis". The purpose of this study is to examine the effect of S-adenosylmethionine therapy in those patients with non-alcoholic liver disease in the form of steatohepatitis (NASH). This will be accomplished by development of a database of these patients, all of whom will have biopsy documented NASH. A place...
What is the current status of trial NCT00108589?
This trial is currently completed. It is a Phase 3 study. The study started on 2004-01. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00108589?
The interventions under investigation include: S-adenosylmethionine (DRUG).
Who is sponsoring clinical trial NCT00108589?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.